607PEvaluation of clinical features of patients diagnosed with spinal muscular atrophy type 1 receiving nusinersen treatment before and after newborn screening program: a multicenter experience in Turkiye
Mustafa Kömür(Mersin Üniversitesi), E. Sarıgecilli, Gamze Sarıkaya Uzan(Dokuz Eylül University), Kristin L. Carman(Eskişehir Osmangazi University), Sema Saltık(Istanbul University-Cerrahpaşa), Emel Çağlar(Mersin Üniversitesi), Hasan Tekgül(Ege University), Didem Ardıçlı(Hacettepe University Hospital), Beril Dilber(Karadeniz Technical University), G. Oz Tuncer(Ondokuz Mayıs University), A. Ceylan(Bilkent University), Gülçin Akıncı(Izmir University), Özlem Yayıcı Köken(Akdeniz University), Ezgi Yıldız(Istanbul University), Özlem Hergüner(Cukurova University), Dilşad Türkdoğan(Marmara University), Leman Tekin Orgun(Başkent University), Uluç Yiş(Dokuz Eylül University)
Cited by 0
Related Papers
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2011|157
Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization
|The American Journal of Human Genetics|2016|106
Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey
|The Journal of Clinical Endocrinology & Metabolism|2016|99
Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome
|The American Journal of Human Genetics|2018|89